A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We present a three-dimensional (3D) in vitro differentiation protocol generating neurospheres of reproducible size to produce cranial neural crest cells from mouse embryonic stem cells. We show that this methodology reduces variability compared to previous protocols and how it can be used for multiplexed assay to study cranial neural crest cell development.
With their remarkable capacity to generate both ectodermal and mesenchymal derivatives, cranial neural crest cells (CNCC) have attracted a lot of interest in studying the mechanisms regulating cell fate decisions and plasticity. Originating in the dorsal neuroepithelium, this cell population is transient and relatively rare in the developing embryo - making functional tests, genomic screens, and biochemistry assays challenging to perform in vivo. To overcome these limitations, several methods have been developed to model CNCC development in vitro. Neurosphere (NS) based culturing methods provide a complex microenvironment that recapitulates the developing anterior neuroepithelium in 3D. These systems allow the growth of many NS in the same plate to generate a large amount of CNCC, but the produced NS present a high variability in shape, size, and number of CNCC formed - making quantitative assays difficult to perform. This protocol outlines a reproducible method for generating NS from mouse embryonic stem cells (mESC) in a 96-well format. NS generated in 96-well plates produce cranial neural crest cells (CNCC), which can be further cultured. By controlling the number of starting cells, this approach reduces variability in the size and shape between NS and increases reproducibility across experiments. Finally, this culture system is adaptable to several applications and offers a higher degree of flexibility, making it highly customizable and suitable for multiplexing experimental conditions.
Cranial neural crest cells (CNCC) are a stem-like cell population that arises in the anteriormost part of the developing embryo, at the border between the neural plate and the surface ectoderm1. CNCC then undergo an epithelial-to-mesenchymal transition (EMT), delaminate from the neuroepithelium, and migrate dorsoventrally towards various locations in the embryo where they differentiate into a wide variety of cell types2. Studying this cell population is of great interest as it possesses a remarkable plasticity3 and the unique ability to differentiate into both ectodermal and mesenchymal derivatives, such as craniofacial bones and cartilages4. Although CNCC are relatively accessible in the embryo, they are a transient population with a low number of cells, making systemic mechanistic studies difficult to conduct in vivo. CNCC cell lines have been isolated and characterized in the last few years to overcome these limitations. In particular, the O9-1 CNCC cell line is a great tool for studying migratory and post-migratory neural crest development5,6; however, this cell line does not allow the study of the early events prior to migration leading to neural crest induction and specification. In this regard, there have been significant developments in the development of in vitro differentiation protocols to differentiate CNCC in a dish via the use of 3D structures resembling the developing neuroepithelium called neurospheres (NS)7,8- obtained after differentiation of embryonic stem cell (ESC) colonies. These 3D protocols robustly produce high numbers of CNCC, allowing the conduct of biochemical and genomic mechanistic studies9,10. NS are cultured on low attachment plates in N2B27 supplemented medium, together with Fibroblast Growth Factor (FGF) and Epidermal Growth Factor (EGF)10,11 to stimulate cell proliferation. These protocols are carried out in Petri dishes, cultivating numerous NS in the same plate. Within the growing NS, cells aggregate and continue to divide - reaching a diameter of 100-200 µm upon maturity. At maturity (about day 5), NS attach to the substrate and differentiate into CNCC resembling their in vivo counterparts9,12. These CNCC then undergo EMT and delaminate onto the plate surface. Morphological differences can be observed depending on NS size, as larger spheres will appear darker in the core due to lower availability of nutrients and oxygen, leading to cells undergoing apoptosis13. While this type of procedure generates a large number of CNCC at the endpoint of differentiation, it presents several limitations, making the study of the various molecular dynamics occurring during the differentiation process nearly impossible. First, the use of ESC colonies - which vary in size - makes it difficult to control the starting cell number for each experiment. This results in the generation of NS of various shapes and diameters that develop differently by activating specific signaling pathways, leading to altered cell differentiation and, thus not forming a uniform sample at a given time point. Second, culturing multiple NS in the same plate often leads to them fusing together14 and potentially releasing signaling molecules that influence their neighbors' microenvironment and, thus, their development. Altogether, these procedures generate a lot of variability between samples and experiments.
Here, we present a strategy to overcome these difficulties that generate single NS - capable of producing CNCC - by aggregating mouse ESC (mESC) in non-TC treated U-bottomed 96-well plates. Starting from mESC allows studying the specification process and early stages of CNCC development compared to starting from already established neural crest cell lines. This protocol begins with the disaggregation of mESC colonies to obtain a single cell suspension, followed by the seeding of a specific number of mESC in each well of a non-TC treated U-bottomed 96-well plate. The cells are left to aggregate for two days and subsequently moved to a non-TC treated flat-bottomed 96-well plate, in which NS will be able to attach to the plate bottom. By controlling the starting cell number and the microenvironment of each NS during the differentiation process, this protocol reduces sample variability, which increases experimental reproducibility. We believe this will be a convenient platform for designing multiplexed experiments, such as testing the effect of different culture conditions or performing gene perturbation screens.
1. Generation of a single-cell suspension from mouse ESC colonies
NOTE: This protocol is adapted to the use of CK35 mESC (an mESC line competent for germ line transmission, to have then the option to develop in vivo models15) grown on inactivated feeders in a gelatin-coated TC-treated 6-well plate. One well of a TC-treated 6-well plate should yield approximately 1.5 × 106 mESC, which is sufficient for the rest of the protocol. This can be scaled up if necessary. Adjust the initial steps in accordance with the chosen ESC strain and maintenance culture method, as well as the proper culture medium. This protocol is to be performed under sterile conditions. See the Table of Materials for details related to all the materials, reagents, and equipment used in this protocol.
2. Transferring into a flat-bottom 96-well plate for CNCC differentiation
3. CNCC passaging and maintenance
NOTE: CNCC passaging can be performed as soon as there is a sufficient quantity of cells visible around NS. This can be as early as day 7, as earlier time points do not provide a sufficient amount of CNCC.
4. NS fixation and mounting for immunofluorescence
5. CNCC fixation and mounting for immunofluorescence
Following the protocol, mESC colonies were dissociated, and 3000 cells were seeded in non-TC treated U-bottom 96-well plates. On day 2, aggregated NS were transferred into non-TC treated flat-bottom 96-well plates to allow them to attach. A simplified visualization of the NS aggregation protocol is provided in Figure 1A. NS were cultured until day 9 and then processed for immunofluorescence staining. Cells that migrated from the NS onto the plate were transferred to coverslips for imaging an...
In vitro 3D differentiation models allow analyzing complex cell interactions that could be difficult - or could not - be observed in 2D cell culture. Several models have been developed to study CNCC development in vitro. These are generally directly derived from ESC colonies7,21 or tissue explants22,23. Although these systems have proven efficient for generating neural crest cells, such ...
The authors declare no conflict of interest.
We thank Dr. Remi Xavier Coux for advice on primer design and expertise in cell culture. This work was supported by the European Research Council (ERC Starting Grant 101039995 - REGENECREST) and the Fondation pour la Recherche Médicale (Amorçage - AJE202205015403).
Name | Company | Catalog Number | Comments |
0.22 μm syringe filters | ClearLine | 146560 | |
15 mL High-Clarity Polypropylene Conical Tube | Falcon | 352096 | |
200 µL ClearLine Plus Low Binding Filter Tips | Dutscher | 713263 | |
40 µm filters | Falcon | 352340 | |
5 mL Serological pipette | Starstedt | 86.1253.001 | |
50 mL High-Clarity Polypropylene Conical Tube | Falcon | 352070 | |
Accutase | Merck-Sigma | A6964 | |
Alexa Fluor 488 donkey anti rabbit IgG (H+L) | Thermofisher Scientific | A21206 | |
Alexa Fluor 594 donkey anti mouse IgG (H+L) | Thermofisher Scientific | A21203 | |
Alexa Fluor 647 donkey anti goat IgG (H+L) | Thermofisher Scientific | A31571 | |
Antibiotic-antimycotic solution | Merck-Sigma | A5955 | |
B27 PLUS supplement | Thermofisher Scientific | 17504044 | |
Bovine serum albumin (BSA) | Merck-Sigma | A9418 | |
Chloroform | Carlo Erba | 438601 | |
Collagenase Type IV | Thermofisher Scientific, Gibco | 17104019 | |
Costar 6 well clear TC-treated multiple well plates | Corning | 3516 | |
Cover glasses, round | VWR | 630-2113 | |
DMEM KnockOut | Thermofisher Scientific | 10829018 | |
DMEM/F12+Glutamax | Thermofisher Scientific | 10565018 | |
DMEM high glucose | Merck-Sigma | D0822 | |
DNA LoBind Tubes, 2 mL | Eppendorf | 30108078 | |
DNase/RNase-Free Distilled Water | Thermofisher Scientific | 10977-035 | |
Dulbecco’s Phosphate Buffered Saline (PBS) | Thermofisher Scientific | 14190144 | |
Eppendorf Safe-Lock Tubes, 0.5 mL | Eppendorf | 30121023 | |
Eppendorf Safe-Lock Tubes, 2 mL | Eppendorf | 30120094 | |
ESGRO mLIF Medium Supplement | Merck-Sigma | ESG1107 | |
Ethanol 70% | Carlo Erba | 528170 | |
Fetal Bovine Serum | Merck-Sigma | F7524 | |
Fibronectin | Merck-Sigma | F085-2MG | |
Fluoromount-G | Invitrogen | 00-4958-02 | |
Gelatin solution | Merck-Sigma | ES-006-B | |
GlutaMAX | Thermofisher Scientific | 35050061 | |
Human EGF | Peprotech | AF-100-15-500UG | |
Human FGF-basic | Peprotech | 100-18B | |
Human SOX9 Antibody | R&Dsystems | AF3075 | |
Insulin from bovine pancreas | Merck-Sigma | I6634 | |
iScript cDNA Synthesis Kit | Biorad | 1708891 | |
Mouse Anti-Human AP-2 alpha Monoclonal Antibody, Unconjugated | DSHB | 3B5 | |
Mouse Anti-Human PAX7 Monoclonal Antibody, Unconjugated | DSHB | PAX7 | |
N2 supplement | Thermofisher Scientific | 17502048 | |
Neurobasal Medium | Thermofisher Scientific | 21103049 | |
Non-Tissue culture treated plate, 96 well, Flat bottom | Falcon | 351172 | |
Non-Tissue culture treated plate, 96 well, U-bottom | Falcon | 351177 | |
Paraformaldehyde 16% solution, em grade | Electron Microscopy Sciences | 15710 | |
Propan-2-ol | Carlo Erba | 415154 | |
Purified anti-Tubulin β 3 (TUJ1) Antibody | Biolegend | MMS-435P | |
RapiClear 1.47 | Sunjin Lab | RC147001 | |
RapiClear 1.52 | Sunjin Lab | RC152001 | |
Scotch Double Sided 12.7 mm × 22.8 m | Clear fibreless double sided tape | ||
SensiFAST SYBR No-ROX Kit | Meridian Bioscience | BIO-98020 | |
Sterile Disposable Surgical Scalpels | Swann-Morton | 05XX | |
Superfrost Plus Adhesion Microscope Slides | Epredia | J1800AMNZ | |
Triton X-100 | Thermofisher Scientific | A16046.AP | |
TRIzol Reagent | FisherScientific | 15596026 | |
Trypsine-EDTA (0.05%) | Thermofisher Scientific | 25300054 | |
Tween-20 | Fisher Scientific | 10113103 | |
TWIST1 Rabbit mAb (IF Formulated) | Cell signaling technology | E7E2G | |
β-mercaptoethanol | Thermofisher Scientific | 31350010 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved